Investors / Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company is a corporate investor based in the United States. Eli Lilly and Company has backed 1 Canadian AI company in the Index, joining 1 tracked round. The most recent was RetiSpec's US$10M Series A in July 2024. Eli Lilly and Company most often invests alongside Alzheimer's Drug Discovery Foundation Diagnostics Accelerator, Centre for Aging + Brain Health Innovation and Discovery Capital (University of Minnesota).
Corporate based in US. 1 Canadian AI company in the Index, 1 tracked round.
- Type
- Corporate
- HQ country
- US
- Companies
- 1
- Tracked rounds
- 1
- Led
- 0
- First tracked deal
- RetiSpec, Jul 2024
- Latest tracked deal
- RetiSpec, Jul 2024
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| RetiSpec | Series A · Jul 2024 · US$10M round | US$10M | — |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Alzheimer's Drug Discovery Foundation Diagnostics Accelerator (1 shared round), Centre for Aging + Brain Health Innovation (1 shared round), Discovery Capital (University of Minnesota) (1 shared round), Gentex Corporation (1 shared round), iGan Partners (1 shared round), Ontario Brain Institute (1 shared round), Topcon Healthcare (1 shared round), Verge HealthTech Fund (1 shared round)
Data as of November 10, 2026.